These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20362714)

  • 1. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study.
    Van Belle E; Dallongeville J; Vicaut E; Degrandsart A; Baulac C; Montalescot G;
    Am Heart J; 2010 Apr; 159(4):570-6. PubMed ID: 20362714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) study.
    Beygui F; Montalescot G; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J;
    Am Heart J; 2009 Apr; 157(4):680-7. PubMed ID: 19332195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty?
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Jimenez-Sosa A; Samimi-Fard S; Idaira HB
    Biomarkers; 2009 Feb; 14(1):43-8. PubMed ID: 19283523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.
    Hjortshøj S; Kristensen SR; Ravkilde J
    Am J Emerg Med; 2010 Feb; 28(2):170-6. PubMed ID: 20159386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.
    Suzuki S; Yoshimura M; Nakayama M; Mizuno Y; Harada E; Ito T; Nakamura S; Abe K; Yamamuro M; Sakamoto T; Saito Y; Nakao K; Yasue H; Ogawa H
    Circulation; 2004 Sep; 110(11):1387-91. PubMed ID: 15353502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
    Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
    Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.
    Tapanainen JM; Lindgren KS; Mäkikallio TH; Vuolteenaho O; Leppäluoto J; Huikuri HV
    J Am Coll Cardiol; 2004 Mar; 43(5):757-63. PubMed ID: 14998613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
    Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
    Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
    J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke.
    Barber M; Morton JJ; Macfarlane PW; Barlow N; Roditi G; Stott DJ
    Cerebrovasc Dis; 2007; 23(4):260-6. PubMed ID: 17199083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Samimi-Fard S; Kaski JC
    Clin Chim Acta; 2008 Feb; 388(1-2):196-9. PubMed ID: 18036561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.